Impact of tumor shrinkage pattern with biweekly triplet gemcitabine+cisplatin+S-1 regimen for biliary tract cancers: Implications for neoadjuvant therapy from the data of KHBO1401 (KHBO1401-1A study)

CONCLUSION: GCS provided faster and greater tumor shrinkage with better survival in comparison to GC, although 20% of patients showed re-growth after 6 cycles.PMID:38048759 | DOI:10.1159/000533669

Source: Oncology - December 4, 2023 Category: Cancer & Oncology Authors: Shogo Kobayashi Hiroshi Wada Daisuke Sakai Hideo Baba Masashi Kanai Hirofumi Kamachi Tadatoshi Takayama Masaki Ueno Masahiro Takahashi Masayuki Sho Kenichi Yoshimura Etsuro Hatano Hiroaki Nagano Tatsuya Ioka Source Type: research